Literature DB >> 28992353

Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy.

Norifumi Hayashi1, Keiichirou Okada1, Yuki Matsui1, Keiji Fujimoto1, Hiroki Adachi1, Hideki Yamaya1, Misao Matsushita2, Hitoshi Yokoyama1.   

Abstract

Background: The M-type phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A (THSD7A) were identified as intrinsic antigens in primary membranous nephropathy (MN). Complement activation via the lectin pathway in intrinsic antigen-related MN is still unclear.
Methods: We retrospectively enrolled 60 primary Japanese MN patients and detected activated complement pathways by staining complement proteins in glomerular deposition. According to the findings of PLA2R and THSD7A staining in glomeruli, they were classified into intrinsic antigen-related or -unrelated MN. We evaluated clinicopathological characteristics and predictors of clinical outcomes in intrinsic antigen-related MN.
Results: Thirty-nine (65%) patients had PLA2R in glomerular deposits and two (3.3%) patients had THSD7A. One of them had both PLA2R and THSD7A (double positive). Forty patients were classified into the intrinsic antigen-related group. The other 20 patients were negative for both antigens (unrelated group). The prevalence and staining intensity of mannose-binding lectin (MBL) deposits were much higher in the intrinsic antigen-related group [55% versus 20%, P < 0.010, 1.0 (interquartile range 1.0-2.0) versus 1.0 (0.0-1.0), P = 0.01, respectively]. The staining intensity of MBL in glomeruli also correlated with the IgG4 staining intensity. In intrinsic antigen-related MN, MBL staining intensity was an unfavorable predictor for remission of proteinuria [hazard ratio (HR) 0.40, P < 0.01] and renal dysfunction (HR 3.81, P = 0.01) in Cox proportional hazards analysis. Moreover, the glomerular MBL-positive group showed more severe interstitial fibrosis and worse clinical outcomes. Conclusions: Intrinsic antigen-related MN was more strongly associated with complement activation by the lectin pathway, which may contribute to a less favorable clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28992353     DOI: 10.1093/ndt/gfx235

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  17 in total

1.  Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.

Authors:  Caixia Tian; Lian Li; Tanxin Liu; Xin Qu; Yurong Qiu
Journal:  Int Urol Nephrol       Date:  2019-06-21       Impact factor: 2.370

2.  Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.

Authors:  George Haddad; Johan M Lorenzen; Hong Ma; Noortje de Haan; Harald Seeger; Christelle Zaghrini; Simone Brandt; Malte Kölling; Urs Wegmann; Bence Kiss; Gábor Pál; Péter Gál; Rudolf P Wüthrich; Manfred Wuhrer; Laurence H Beck; David J Salant; Gérard Lambeau; Andreas D Kistler
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 3.  The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice.

Authors:  Iwona Smarz-Widelska; Dariusz Chojęta; Małgorzata M Kozioł
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

4.  Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits.

Authors:  Xu Yu-Zhu; Huang Na-Ya; Qiu Ya-Gui; Chen Xiong-Hui; Li Zhi-Jian; Chen Wei; Wang Xin
Journal:  Clin Exp Med       Date:  2021-10-26       Impact factor: 5.057

Review 5.  A New Classification System for IgG4 Autoantibodies.

Authors:  Inga Koneczny
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

Review 6.  Immunology of membranous nephropathy.

Authors:  Shin'ichi Akiyama; Enyu Imai; Shoichi Maruyama
Journal:  F1000Res       Date:  2019-05-24

7.  Clinical significance of C4d deposition in renal tissues from patients with primary Sjögren's syndrome-a preliminary study.

Authors:  Wenli Xia; Bixia Gao; Lin Duan; Yan Li; Yubing Wen; Limeng Chen; Xuemei Li; Falei Zheng; Mingxi Li
Journal:  BMC Nephrol       Date:  2019-05-28       Impact factor: 2.388

Review 8.  Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.

Authors:  Wenbin Liu; Chang Gao; Haoran Dai; Yang Zheng; Zhaocheng Dong; Yu Gao; Fei Liu; Zihan Zhang; Zhiyuan Liu; Weijing Liu; Baoli Liu; Qingquan Liu; Jialan Shi
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

Review 9.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 10.  Advances of the experimental models of idiopathic membranous nephropathy (Review).

Authors:  Han Xue Jiang; Zhendong Feng; Ze Bing Zhu; Chen Hui Xia; Wenting Zhang; Jing Guo; Bao-Li Liu; Yaoxian Wang; Yu Ning Liu; Wei Jing Liu
Journal:  Mol Med Rep       Date:  2020-03-09       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.